Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes-Reference-Cited by-同舟云学术

Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes

Published:2020-06 Issue: Volume:20 Page:34-49
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Chakraborty Samrat,Dlie Zewdu Yilma,Chakraborty Somdyuti,Roy Somdatta,Mukherjee Biswajit,Besra Shila Elizabeth,Dewanjee Saikat,Mukherjee Alankar,Ojha Probir Kumar,Kumar Vinay,Sen Ramkrishna

Funder

(UGC), New Delhi, India

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference68 articles.

1. Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma;Li;Int. J. Nanomedicine,2016

2. Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma;Ladju;Oncotarget,2017

3. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?;Trachootham;Nat. Rev. Drug Discov.,2009

4. Targeted therapy for hepatocellular carcinoma: challenges and opportunities;Chen;Cancer Lett.,2019

5. Nanomedicine in management of hepatocellular carcinoma: challenges and opportunities;Mohamed;Int. J. Cancer,2017

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment;Journal of Biomedical Science;2024-08-20

2. Telmisartan loaded lipid nanocarrier as a potential repurposing approach to treat glioma: characterization, apoptosis evaluation in U87MG cells, pharmacokinetic and molecular simulation study;Nanotechnology;2024-08-01

3. Recent progress in stimuli-responsive polymeric micelles for targeted delivery of functional nanoparticles;Advances in Colloid and Interface Science;2024-08

4. Folic acid-tripeptide-conjugated synthetic biodegradable nanoparticle-loaded with Ormeloxifene potentially inhibited breast cancer xenograft tumor;Journal of Drug Delivery Science and Technology;2024-08

5. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives;International Journal of Pharmaceutics;2024-07